Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity

Medicine & Life Sciences

• Insulin-Like Growth Factor Binding Protein 3 100%
• Proto-Oncogene Proteins c-akt 94%
• Somatomedins 84%
• Phosphatidylinositol 3-Kinase 80%
• IGF Type 1 Receptor 30%
• Insulin-Like Growth Factor I 16%
• Cattle 12%
• Fibroblasts 11%
• Okadaic Acid 10%
• polyacrylamide gels 9%
• 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 9%
• 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 9%
• Phosphoprotein Phosphatases 9%
• Threonine 8%
• Proline 8%
• Mitogen-Activated Protein Kinases 7%
• Phosphatidylinositol 3-Kinases 7%
• Acids 5%
• Ligands 5%
• Phosphorylation 5%
• Antibodies 4%